Agilon Health, Inc. (NYSE:AGL) Given Consensus Recommendation of “Hold” by Analysts

Agilon Health, Inc. (NYSE:AGL) has been assigned an average recommendation of “Hold” from the fourteen brokerages that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and five have issued a buy rating on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $91.30.

Several analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft upgraded Agilon Health from a “hold” rating to a “buy” rating and lifted their target price for the stock from $33.00 to $49.00 in a research report on Thursday, May 7th. Truist Financial set a $112.00 price target on shares of Agilon Health and gave the stock a “hold” rating in a research note on Thursday, August 6th. TD Cowen reiterated a “hold” rating and set a $55.00 price objective (up from $17.00) on shares of Agilon Health in a report on Monday, May 11th. Barclays set a $111.00 price objective on shares of Agilon Health and gave the company an “equal weight” rating in a research report on Thursday, August 6th. Finally, Wall Street Zen upgraded shares of Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th.

Agilon Health Trading Down 0.3%

AGL opened at $96.32 on Monday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.08 and a current ratio of 1.08. The stock’s 50 day moving average price is $105.84 and its 200-day moving average price is $61.17. Agilon Health has a one year low of $7.48 and a one year high of $133.04. The stock has a market cap of $1.62 billion, a price-to-earnings ratio of -6.75 and a beta of 3.01.

Agilon Health (NYSE:AGL) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.90. The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.45 billion. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%. On average, equities analysts forecast that Agilon Health will post -2.95 EPS for the current year.

Institutional Trading of Agilon Health

A number of large investors have recently modified their holdings of the company. LPL Financial LLC increased its holdings in Agilon Health by 213.4% during the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after purchasing an additional 30,000 shares during the period. Krilogy Financial LLC bought a new position in shares of Agilon Health during the 4th quarter worth $34,000. CIBC Bancorp USA Inc. bought a new position in shares of Agilon Health during the 3rd quarter worth $34,000. Merit Financial Group LLC purchased a new position in shares of Agilon Health during the fourth quarter valued at $35,000. Finally, Focus Partners Advisor Solutions LLC purchased a new position in shares of Agilon Health during the fourth quarter valued at $53,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.